Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PI 3-kinase, mTOR, protein synthesis and cancer.

Literature DB >> 11689313

PI 3-kinase, mTOR, protein synthesis and cancer.

P K Vogt.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2001 PMID： 11689313 DOI： 10.1016/s1471-4914(01)02161-x

Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

1. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.

Authors: Meilin Ma; Xiangming Wang; Xiaochang Chen; Rui Cai; Fenfen Chen; Wuzi Dong; Gongshe Yang; Weijun Pang
Journal: RNA Biol Date: 2017-01-13 Impact factor: 4.652

Review 2. Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors: Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal: Med Res Rev Date: 2014-08-28 Impact factor: 12.944

3. Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

Authors: Simrit Parmar; Jessica Smith; Antonella Sassano; Shahab Uddin; Efstratios Katsoulidis; Beata Majchrzak; Suman Kambhampati; Elizabeth A Eklund; Martin S Tallman; Eleanor N Fish; Leonidas C Platanias
Journal: Blood Date: 2005-03-24 Impact factor: 22.113

4. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase.

Authors: Yaniv Lustig; Jorge L Ruas; Jennifer L Estall; James C Lo; Srikripa Devarakonda; Dina Laznik; Jang Hyun Choi; Hiraku Ono; Jesper V Olsen; Bruce M Spiegelman
Journal: Genes Dev Date: 2011-06-06 Impact factor: 11.361

5. Efficacy of rapamycin against glioblastoma cancer stem cells.

Authors: M Mendiburu-Eliçabe; J Gil-Ranedo; M Izquierdo
Journal: Clin Transl Oncol Date: 2013-09-17 Impact factor: 3.405

6. Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition.

Authors: Juanjuan Ou; Hongming Miao; Yinyan Ma; Feng Guo; Jia Deng; Xing Wei; Jie Zhou; Ganfeng Xie; Hang Shi; Bingzhong Xue; Houjie Liang; Liqing Yu
Journal: Cell Rep Date: 2014-12-04 Impact factor: 9.423

PI 3-kinase, mTOR, protein synthesis and cancer.

1. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.

Review 2. Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

3. Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells.

4. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase.

5. Efficacy of rapamycin against glioblastoma cancer stem cells.

6. Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition.

7. Arsenite induces p70S6K1 activation and HIF-1alpha expression in prostate cancer cells.

8. Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.

Review 9. Genes and pathways driving glioblastomas in humans and murine disease models.

10. Glioblastoma Multiforme Oncogenomics and Signaling Pathways.